1,4-Dihydropyrano[2,3-c]pyrazole

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 1,4-Dihydropyrano[2,3-c]pyrazole
• 英文别名: 1,4-dihydropyrano[2,3-c]pyrazole
• 化学式: C₆H₆N₂O
• 分子量: 122.12
• InChiKey: HZKPKAKLGRSCJS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  37.9
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• SHMT Inhibitors
  申请人：The Trustees of Princeton University

  公开号：US20180072751A1

  公开（公告）日：2018-03-15

  The disclosure provides compounds of Formulae (I)-(IX). The disclosed compounds are capable of inhibiting a mammalian SHMT. Compounds of the disclosure have numerous uses, such as for treatment of cancer or autoimmune disorders.

  本公开提供了式(I)-(IX)的化合物。所述公开的化合物能够抑制哺乳动物的丝氨酸羟甲基转移酶。本公开的化合物有多种用途，例如用于治疗癌症或自身免疫性疾病。
• [EN] 6-AMINO-2,4-DIHYDROPYRANO [2,3-C] PYRAZOLES AND METHODS OF USE<br/>[FR] 6-AMINO-2,4-DIHYDROPYRANO [2,3-C] PYRAZOLES ET PROCÉDÉS D'UTILISATION
  申请人：PURDUE RESEARCH FOUNDATION

  公开号：WO2018183587A1

  公开（公告）日：2018-10-04

  The present invention generally relates to 6-amino-2,4-dihydropyrano [2,3-c] pyrazoles as a ubiquitin specific protease 7 (USP7) inhibitor useful for the treatment of diseases mediated by malfunction of USP7, such as inflammation, cancer, and immunological disorders. The invention described herein also pertains to pharmaceutical compositions and methods for treating diseases mediated by malfunction of USP7, in mammals using compounds disclosed herein.

  本发明通常涉及6-氨基-2,4-二氢吡喃并[2,3-c]吡唑醇作为一种泛素特异性蛋白酶7（USP7）抑制剂，用于治疗由USP7功能失调介导的疾病，如炎症、癌症和免疫性疾病。本文所述的发明还涉及使用本文披露的化合物在哺乳动物中治疗由USP7功能失调介导的疾病的药物组合物和方法。
• SHMT inhibitors
  申请人：The Trustees of Princeton University

  公开号：US10077273B2

  公开（公告）日：2018-09-18

  The disclosure provides compounds of Formulae (I)-(IX). The disclosed compounds are capable of inhibiting a mammalian SHMT. Compounds of the disclosure have numerous uses, such as for treatment of cancer or autoimmune disorders.

  本公开提供了式 (I)-(IX) 的化合物。所公开的化合物能够抑制哺乳动物 SHMT。所公开的化合物具有多种用途，如治疗癌症或自身免疫性疾病。
• 6-amino-2,4-dihydropyrano [2,3-c] pyrazoles and methods of use
  申请人：Purdue Research Foundation

  公开号：US10980781B2

  公开（公告）日：2021-04-20

  The present invention generally relates to 6-amino-2,4-dihydropyrano [2,3-c] pyrazoles as a ubiquitin specific protease 7(USP7) inhibitor useful for the treatment of diseases mediated by malfunction of USP7, such as inflammation, cancer, and immunological disorders. The invention described herein also pertains to pharmaceutical compositions and methods for treating diseases mediated by malfunction of USP7, in mammals using compounds disclosed herein.

  本发明一般涉及作为泛素特异性蛋白酶7（USP7）抑制剂的6-氨基-2,4-二氢吡喃并[2,3-c]吡唑，可用于治疗由USP7功能失调介导的疾病，如炎症、癌症和免疫紊乱。本文所述的发明还涉及使用本文公开的化合物治疗哺乳动物中由 USP7 功能失常介导的疾病的药物组合物和方法。
• POLYCYCLIC DERIVATIVES TARGETING RAL GTPASES AND THEIR THERAPEUTICAL APPLICATIONS
  申请人：NANTBIO, INC.

  公开号：US20180170942A1

  公开（公告）日：2018-06-21

  Contemplated compounds, compositions and methods are directed to Ral GTPase inhibitors with improved activity.